Matthew J D'Onofrio is Chief Executive Officer of Evoke Pharma Inc. Currently has a direct ownership of 8,820 shares of EVOK, which is worth approximately $4,145. The most recent transaction as insider was on Feb 28, 2025, when has been sold 6,849 shares (Common Stock) at a price of $3.65 per share, resulting in proceeds of $24,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.82K
96.89% 3M change
96.89% 12M change
Total Value Held $4,145

Matthew J D'Onofrio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2025
BUY
Grant, award, or other acquisition
$24,998 $3.65 p/Share
6,849 Added 43.71%
8,820 Common Stock
Dec 11 2020
SELL
Open market or private sale
$117,439 $2.91 p/Share
40,357 Reduced 12.44%
283,997 Common Stock
Dec 10 2020
SELL
Open market or private sale
$16,647 $2.95 p/Share
5,643 Reduced 1.71%
324,354 Common Stock
Dec 09 2020
BUY
Exercise of conversion of derivative security
$18,400 $0.4 p/Share
46,000 Added 12.23%
329,997 Common Stock
MJD

Matthew J D'Onofrio

Chief Executive Officer
Solana Beach, CA

Track Institutional and Insider Activities on EVOK

Follow Evoke Pharma Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVOK shares.

Notify only if

Insider Trading

Get notified when an Evoke Pharma Inc insider buys or sells EVOK shares.

Notify only if

News

Receive news related to Evoke Pharma Inc

Track Activities on EVOK